Assessment of individual hematopoietic stem cell response to gamma exposure using humanized mice

Author:

Atamanyuk NI1ORCID,Pryakhin EA1ORCID,Styazhkina EV1ORCID,Obvintseva NA1ORCID,Tryapitsyna GA1,Peretykin AA1,Andreev SS1,Aldibekova AE1,Akleyev AV1ORCID

Affiliation:

1. Urals Research Center for Radiation Medicine of the Federal Medical Biological Agency, Chelyabinsk, Russia

Abstract

Assessment of individual responses of cells, tissues and the whole body to radiation exposure is an important challenge for radiobiology and radiation safety. The study was aimed to develop the method for estimation of the human hematopietic stem cell (HSC) individual response in the humanized mouse model. The cord blood or peripheral blood HSCs were administered to the NOD SCID immunodeficient mice. The number of maturing HSCs (CD34+ cells) and mature CD45+ leukocytes was assesed after the acute gamma exposure to the doses of 0.5 Gy, 1 Gy, and 1.5 Gy, along with the HSC share among all CD45low/+ cells within three days (period of maximum mortality) and 14 days (period of active restoration) after exposure. The relationship between the indicato values and the exposure dose was calculated by regression analysis. There was exponential relationship between the human HSC survival rate in humanized mice and the dose on day three after exposure (R2 = 0.93; F = 211; p < 0.01), while the relationship between the number of HSCs and the dose on day 14 after exposure was linear (R2 = 0.65; F = 12.9; p = 0.01). The C14/3 coefficient calculated as a ratio of the HSC share among all human CD45low/+ cells on day 14 after exposure to the same parameter on day three after exposure was proposed as an indicator of HSC mortality and HSC number restoration. C14/3 negatively correlated with the exposure dose (R2 = 0.57; F = 13.3; p = 0.004), it was higher in radioresistant mice and the model of cysteamine-induced radioresistance in humanized mice. The model mice humanized using the peripheral blood HSCs can be used to assess individual HSC response to acute external gamma exposure based on C14/3 and the data on the HSC survival and restoration.

Publisher

Federal Medical Biological Agency

Subject

General Chemical Engineering,General Chemistry,Ecology, Evolution, Behavior and Systematics,Organic Chemistry,Biochemistry,Drug Discovery,Bioengineering,Cardiology and Cardiovascular Medicine,Ophthalmology,Political Science and International Relations,Communication,General Chemical Engineering,General Chemistry,Law,Sociology and Political Science,Developmental Biology

Reference25 articles.

1. Xaitov RM, Akleev AV, Kofiadi IA. Individual'naya radiochuvstvitel'nost' i immunitet: nacional'noe rukovodstvo. Chelyabinsk: Kniga, 2018; 216 s. Russian.

2. Applegate KE, Rühm W, Wojcik A, Bourguignon M, Brenner A, Hamasaki K, et al Individual response of humans to ionising radiation: governing factors and importance for radiological protection. Radiat Environ Biophys. 2020; 59 (2): 185–209. DOI: 10.1007/s00411-020-00837-y. PMID: 32146555.

3. Human Radiosensitivity. Report of the independent Advisory Group on Ionising Radiation Documents of the Health Protection Agency. London, 2013; 164 p.

4. Ferlazzo ML, Bourguignon M, Foray N. Functional Assays for Individual Radiosensitivity: A Critical Review. Semin Radiat Oncol. 2017; 27 (4): 310–5. DOI: 10.1016/j.semradonc.2017.04.003. PMID: 28865513.

5. Kogarko IN, Akleev AV, Petushkova VV, Nejfax EA, Kogarko BS, Ktitorova OV, i dr. Adaptivnyj otvet kak kriterij ocenki individual'noj radiochuvstvitel'nosti cheloveka. Radiaciya i risk (Byulleten' NREhR). 2022; 1. Dostupno po ssylke: https://cyberleninka.ru/article/n/adaptivnyy-otvet-kak-kriteriy-otsenki-individualnoy-radiochuvstvitelnosti-cheloveka-obzor (data obrashheniya: 08.11.2022). Russian.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3